Literature DB >> 26167999

Vision Loss due to Central Retinal Artery Occlusion Following Embolization in a Case of a Giant Juvenile Nasopharyngeal Angiofibroma.

Mihir Trivedi1, Roshani J Desai, Nayana A Potdar, Chhaya A Shinde, Vivek Ukirde, Maunil Bhuta, Akshay Gopinathan Nair.   

Abstract

Juvenile nasopharyngeal angiofibroma (JNA) is a benign, vascular, and locally aggressive tumor that arises in the nasal cavity, extending into the nasopharynx and often in to the orbit. It may rarely present to the ophthalmologist with proptosis and optic neuropathy. Preoperative embolization of JNA is done before surgical resection. In this communication, the authors report a rare occurrence of ipsilateral central retinal artery occlusion (CRAO) following embolization with polyvinyl alcohol in a 13-year-old boy with right-sided JNA. Retrospective review of the angiograms pointed out to a suspicious communication between the external carotid artery and the ophthalmic vessels. Pre-embolization detailed study of the angiograms is necessary to avoid such devastating complications. Although rare, vision loss is a possible complication arising from embolization of nasopharyngeal and intracranial tumors, and all patients undergoing these procedures should be informed of the risk of visual loss because it has a lasting impact on the quality of life.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26167999     DOI: 10.1097/SCS.0000000000001936

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  2 in total

1.  Juvenile Nasopharyngeal Angiofibroma: Our Experience in a Tertiary Hospital.

Authors:  M Mujtaba Khan; L Sudarshan Reddy; N Venkatram Reddy; D Ranganath Swamy
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2017-11-22

2.  Comprehensive preoperative staging system for endoscopic single and multicorridor approaches to juvenile nasal angiofibromas.

Authors:  Trichy N Janakiram; Shilpee B Sharma; Ekkehard Kasper; Onkar Deshmukh; Iype Cherian
Journal:  Surg Neurol Int       Date:  2017-04-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.